Oxadiazoles in Medicinal Chemistry

被引:529
|
作者
Bostrom, Jonas [1 ]
Hogner, Anders [1 ]
Llinas, Antonio [1 ]
Wellner, Eric [1 ]
Plowright, Alleyn T. [1 ]
机构
[1] AstraZeneca R&D, S-43183 Molndal, Sweden
关键词
DRUG-LIKE PROPERTIES; RECEPTOR ANTAGONISTS; CARBOXYLIC-ACIDS; DISCOVERY; 1,3,4-OXADIAZOLES; INHIBITORS; LIPOPHILICITY; PHARMACOLOGY; REPLACEMENTS; SELECTIVITY;
D O I
10.1021/jm2013248
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Oxadiazoles are five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom, and they exist in different regioisomeric forms. Oxadiazoles are frequently occurring motifs in druglike molecules, and they are often used with the intention of being bioisosteric replacements for ester and amide functionalities. The current study presents a systematic comparison of 1,2,4- and 1,3,4-oxadiazole matched pairs in the AstraZeneca compound collection. In virtually all cases, the 1,3,4-oxadiazole isomer shows an order of magnitude lower lipophilicity (log D), as compared to its isomeric partner. Significant differences are also observed with respect to metabolic stability, hERG inhibition, and aqueous solubility, favoring the 1,3,4-oxadiazole isomers. The difference in profile between the 1,2,4 and 1,3,4 regioisomers can be rationalized by their intrinsically different charge distributions (e.g., dipole moments). To facilitate the use of these heteroaromatic rings, novel synthetic routes for ready access of a broad spectrum of 1,3,4-oxadiazoles, under mild conditions, are described.
引用
收藏
页码:1817 / 1830
页数:14
相关论文
共 50 条
  • [31] Fragment-to-Lead Medicinal Chemistry Publications in 2020
    de Esch, Iwan J. P.
    Erlanson, Daniel A.
    Jahnke, Wolfgang
    Johnson, Christopher N.
    Walsh, Louise
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (01) : 84 - 99
  • [32] The Fifth Element in Drug Design: Boron in Medicinal Chemistry
    Kahlert, Jan
    Austin, Christopher J. D.
    Kassiou, Michael
    Rendina, Louis M.
    AUSTRALIAN JOURNAL OF CHEMISTRY, 2013, 66 (10) : 1118 - 1123
  • [33] Fragment-to-Lead Medicinal Chemistry Publications in 2023
    Holvey, Rhian S.
    Erlanson, Daniel A.
    de Esch, Iwan J. P.
    Farkas, Barbara
    Jahnke, Wolfgang
    Nishiyama, Tsuyoshi
    Woodhead, Andrew J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (02) : 986 - 1001
  • [34] Designing of kinase hinge binders: A medicinal chemistry perspective
    Sharma, Vikas
    Gupta, Mohit
    CHEMICAL BIOLOGY & DRUG DESIGN, 2022, 100 (06) : 968 - 980
  • [35] Thioamides in medicinal chemistry and as small molecule therapeutic agents
    Huang, Guang
    Cierpicki, Tomasz
    Grembecka, Jolanta
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 277
  • [36] The Role of Allylic Strain for Conformational Control in Medicinal Chemistry
    Zhao, Hongtao
    Branalt, Jonas
    Perry, Matthew
    Tyrchan, Christian
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (12) : 7730 - 7755
  • [37] The role of fluorine in medicinal chemistry
    Shah, Poonam
    Westwell, Andrew D.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2007, 22 (05) : 527 - 540
  • [38] Back to the Medicinal Chemistry Future
    Giustiniano, Mariateresa
    Gruber, Christian W.
    Kent, Caitlin N.
    Trippier, Paul C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (21) : 15515 - 15518
  • [39] Boron in Medicinal and Organic Chemistry
    Bruno Prates, Joao Lucas
    Pavan, Aline Renata
    dos Santos, Jean Leandro
    CURRENT ORGANIC CHEMISTRY, 2021, 25 (16) : 1853 - 1867
  • [40] Feature Reviews in Medicinal Chemistry
    Meegan, Mary J.
    PHARMACEUTICALS, 2025, 18 (02)